| May 9, 2000
Media
Contacts:
Kim McDonald (858) 534-7572,
or Jim Keeley, HHMI, (301)
215-8858
UCSD
CHEMIST SELECTED FOR COMPUTATIONAL BIOLOGY INITIATIVE BY HOWARD HUGHES
MEDICAL INSTITUTE
J. Andrew McCammon, a chemistry professor at the University of
California, San Diego, has been selected in a national competition by
the Howard Hughes Medical Institute as one of 12 leading scientists
who will become HHMI investigators in the emerging field of
computational biology.
McCammon, who uses sophisticated computer models to examine how
protein molecules function so that new enzymes and effective new drugs
can be developed, was selected by HHMI as part of a new initiative to
pursue growing scientific opportunities at the confluence of biology
and computing, in areas such as genomics, cognitive neuroscience and
the folding of biomolecules.
The honor was part of an announcement yesterday by the institute
naming McCammon, the Joseph E. Mayer professor of theoretical
chemistry and a professor of pharmacology at UCSD, and 47 other
scientists from 31 institutions across the country as HHMI
investigators. These scientists will join 305 other HHMI
investigators, who are provided from $500,000 to $1-million annually
by the institute for research, graduate training, library resources
and other needs.
The institute’s computational-biology initiative, which includes
a physicist and an engineer, illustrating the breadth of the fields
that now contribute to biomedical advances, will build on recent
efforts by scientists to solve important biological problems with new
computational tools. McCammon is part of a group of biologists,
chemists, medical researchers, computer scientists and engineers
working together at UCSD to do that in a comprehensive way at the
forefront of a new field called bioinformatics.
"The HHMI award will allow us to intensify our current efforts
to move from the molecular to the cellular level of computational
structural biology," said McCammon. "It was a real surprise
to be selected—there were so many outstanding nominees."
"Andy McCammon has been an inspirational force at UCSD,"
said Mark H. Thiemens, professor of chemistry and dean of the Division
of Natural Sciences at UCSD. "His work here has been
simultaneously successful in not only bringing together multiple
disciplines, he has also brought to the university the real power of
computation. The Howard Hughes investigatorship will be a tremendous
opportunity for Andy and this will further elevate his leadership in
computational chemistry."
"Andy is an outstanding computational chemist who is at the
forefront of the bioinformatics revolution," said Edward A.
Dennis, professor and chair of UCSD’s department of chemistry and
biochemistry. "He works at the interface of chemistry,
pharmacology, biology, and physics and is a true Renaissance scientist
who is well equipped to move the bioinformatics field forward. He has
earned this recognition and will do great things as a HHMI
investigator."
McCammon is the recipient of the George Hitchings Award for
Innovative Methods in Drug Design, the Computerworld-Smithsonian Award
for Breakthrough Computational Science and this year was elected, with
Thomas D. Pollard, an adjunct professor of chemistry and biochemistry
at UCSD, to the first class of fellows to the Biophysical Society. A
list of current research projects and accomplishments in computational
biology and chemistry can be found at the McCammon research group’s
web site at http://mccammon.ucsd.edu |